Biomedical Engineering Reference
In-Depth Information
. 65.. Kos,.K..S.,.Zhou,.X..Y.,.Lee,.S.,.Zhang,.L..L.,.Yang,.W..T.,.Nagata,.Y.,.and.Yu,.D..H.,.Combined.
trastuzumab. and. paclitaxel. treatment. better. inhibits. ErbB-2-mediated. angiogenesis. in. breast.
carcinoma.through.a.more.effective.inhibition.of.Akt.than.either.treatment.alone,.
Cancer
.98.(7),.
1377-1385,.2003.
. 66.. Cuello,. M.,. Ettenberg,. S.. A.,. Clark,. A.. S.,. Keane,. M.. M.,. Posner,. R.. H.,. Nau,. M.. M.,. Dennis,.
P..A.,.and.Lipkowitz,.S.,.Down-regulation.of.the.erbB-2.receptor.by.trastuzumab.(Herceptin).
enhances.tumor.necrosis.factor-related.apoptosis-inducing.ligand-mediated.apoptosis.in.breast.
and.ovarian.cancer.cell.lines.that.overexpress.erbB-2,.
Cancer Research
.61.(12),.4892-4900,.2001.
. 67.. Smith,. I.. E.,. Eficacy. and. safety. of. Herceptin. (R). in. women. with. metastatic. breast. cancer:.
results.from.pivotal.clinical.studies,.in.
25th Congress of the European Society of Medical Oncology
,.
Lippincott.Williams.&.Wilkins,.Hamburg,.Germany,.2000,.pp..S3-S10.
. 68.. Cobleigh,. M..A.,. Vogel,. C.. L.,. Tripathy,. D.,. Robert,. N.. J.,. Scholl,. S.,. Fehrenbacher,. L.,. Wolter,.
J.. M.,. Paton,. V.,. Shak,. S.,. Lieberman,. G.,. and. Slamon,. D.. J.,. Multinational. study. of. the. efi-
cacy. and. safety. of. humanized. anti-HER2. monoclonal. antibody. in. women. who. have. HER2-
overexpressing.metastatic.breast.cancer.that.has.progressed.after.chemotherapy.for.metastatic.
disease,.
Journal of Clinical Oncology
.17.(9),.2639-2648,.1999.
. 69.. Romond,. E.. H.,. Perez,. E..A.,. Bryant,. J.,. Suman,. V.. J.,. Geyer,. C.. E.,. Davidson,. N.. E.,. Tan-Chiu,. E.,.
Martino,.S.,.Paik,.S.,.Kaufman,.P..A.,.Swain,.S..M.,.Pisansky,.T..M.,.Fehrenbacher,.L.,.Kutteh,.L..A.,.
Vogel,.V..G.,.Visscher,.D..W.,.Yothers,.G.,.Jenkins,.R..B.,.Brown,.A..M.,.Dakhil,.S..R.,.Mamounas,.E..P.,.
Lingle,.W..L.,.Klein,.P..M.,.Ingle,.J..N.,.and.Wolmark,.N.,.Trastuzumab.plus.adjuvant.chemotherapy.
for.operable.HER2.positive.breast.cancer,.
New England Journal of Medicine
.353.(16),.1673-1684,.2005.
. 70.. Hussain,. M.. H.. A.,. MacVicar,. G.. R.,. Petrylak,. D.. P.,. Dunn,. R.. L.,. Vaishampayan,. U.,. Lara,.
P.. N.,. Chatta,. G.. S.,. Nanus,. D.. M.,. Glode,. L.. M.,. Trump,. D.. L.,. Chen,. H.,. and. Smith,. D.. C.,.
Trastuzumab,.paclitaxel,.carboplatin,.and.gemcitabine.in.advanced.human.epidermal.growth.
factor.receptor-2/neu-positive.urothelial.carcinoma:.results.of.a.multicenter.phase.II.National.
Cancer.Institute.trial,.
Journal of Clinical Oncology
.25.(16),.2218-2224,.2007.
. 71.. Coudert,. B.. P.,.Arnould,. L.,. Moreau,. L.,. Chollet,. P.,. Weber,. B.,. Vanlemmens,. L.,. Molucon,. C.,.
Tubiana,.N.,.Causeret,.S.,.Misset,.J..L.,.Feutray,.S.,.Mery-Mignard,.D.,.Garnier,.J.,.and.Fumoleau,.
P.,.Pre-operative.systemic.(neo-adjuvant).therapy.with.trastuzumab.and.docetaxel.for.HER2-
overexpressing. stage. II. or. III. breast. cancer:. results. of. a. multicenter. phase. II. trial,.
Annals of
Oncology
.17.(3),.409-414,.2006.
. 72.. Piccart-Gebhart,.M..J.,.Procter,.M.,.Leyland-Jones,.B.,.Goldhirsch,.A.,.Untch,.M.,.Smith,.I.,.Gianni,.
L.,.Baselga,.J.,.Bell,.R.,.Jackisch,.C.,.Cameron,.D.,.Dowsett,.M.,.Barrios,.C..H.,.Steger,.G.,.Huang,.
C.. S.,. Andersson,. M.,. Inbar,. M.,. Lichinitser,. M.,. Lang,. I.,. Nitz,. U.,. Iwata,. H.,. Thomssen,. C.,.
Lohrisch,.C.,.Suter,.T..M.,.Ruschoff,.J.,.Suto,.T.,.Greatorex,.V.,.Ward,.C.,.Straehle,.C.,.McFadden,.
E.,.Dolci,.M..S.,.Gelber,.R..D.,.and.Team,.H..T..S.,.Trastuzumab.after.adjuvant.chemotherapy.in.
HER2.positive.breast.cancer,.
New England Journal of Medicine
.353.(16),.1659-1672,.2005.
. 73.. Baselga,.J.,.Norton,.L.,.Albanell,.J.,.Kim,.Y..M.,.and.Mendelsohn,.J.,.Recombinant.humanized.
anti-HER2.antibody.(Herceptin
(TM)
).enhances.the.antitumor.activity.of.paclitaxel.and.doxorubi-
cin.against.HER2/neu.overexpressing.human.breast.cancer.xenografts,.
Cancer Research
.58.(13),.
2825-2831,.1998.
. 74.. Burstein,.H..J.,.Harris,.L..N.,.Gelman,.R.,.Lester,.S..C.,.Nunes,.R..A.,.Kaelin,.C..M.,.Parker,.L..M.,.
Ellisen,.L..W.,.Kuter,.I.,.Gadd,.M..A.,.Christian,.R..L.,.Kennedy,.P..R.,.Borges,.V..F.,.Bunnell,.C..
A.,.Younger,.J.,.Smith,.B..L.,.and.Winer,.E..P.,.Preoperative.therapy.with.trastuzumab.and.pacli-
taxel.followed.by.sequential.adjuvant.doxorubicin/cyclophosphamide.for.HER2.overexpress-
ing.stage.II.or.III.breast.cancer:.a.pilot.study,.
Journal of Clinical Oncology
21.(1),.46-53,.2003.
. 75.. Seidman,. A.. D.,. Fornier,. M.. N.,. Esteva,. F.. J.,. Tan,. L.,. Kaptain,. S.,. Bach,. A.,. Panageas,. K.. S.,.
Arroyo,.C.,.Valero,.V.,.Currie,.V.,.Gilewski,.T.,.Theodoulou,.M.,.Moynahan,.M..E.,.Moasser,.M.,.
Sklarin,.N.,.Dickler,.M.,.D'Andrea,.G.,.Cristofanilli,.M.,.Rivera,.E.,.Hortobagyi,.G..N.,.Norton,.
L.,.and.Hudis,.C..A.,.Weekly.trastuzumab.and.paclitaxel.therapy.for.metastatic.breast.cancer.
with.analysis.of.eficacy.by.HER2.immunophenotype.and.gene.ampliication,.
Journal of Clinical
Oncology
.19.(10),.2587-2595,.2001.
